JUN 10, 2015 12:30 PM PDT

Colon Cancer Diagnostic Tool

Speaker
  • SE Regional Manager, Hemosure
    Biography
      Rob Kisfalusi is a specialty expert in rapid diagnostic medical devices with enthusiasm for Colorectal Cancer Awareness. Selling a medical device is one thing, but making an impact on the lives of people is far more rewarding. His belief is that we are all part of a team and the goals of the team are simple: Save lives and/or make the quality of life better for people. The tasks may differ, but the goal should remain. Rob's favorite task is educating healthcare providers on new recommendations and methodologies. He loves to see the 'aha' moment when they not only understand how to perform a test, but more importantly, why. Rob will continue to learn, educate and disseminate beneficial information to the masses.

    Abstract
    Discussion of the guaiac based test introduced in 1971 and its' shortcomings versus Fecal Immunochemical Testing (FIT) and how it relates to acute and non-acute facilities. Why is FIT the preferred test? What is Colorectal Cancer and why do I care about it? How important is awareness and detection? Why is screening important and how is it done? Recommended screening tests and other tests available History of guaiac-based cards and specific prep DRE Warning ACG recommendation from 2008 FIT Advantages Other countries Usage stats Side - by - Side comparison, guaiac vs. FIT Comparison of various FIT and discussion regarding cutoff levels Summary: CRC Is the 2nd leading killer in Cancers The ACG recommends ABANDONING older gFOBT DRE is NOT an acceptable form of CRC screening, even when used with a guaiac-based card. FIT has higher patient compliance rate FIT may generate significant revenue to your practice The GOLD STANDARD is whichever recommended test you can actually get the patient to complete.

    Show Resources
    You May Also Like
    APR 07, 2020 8:00 AM PDT
    C.E. CREDITS
    APR 07, 2020 8:00 AM PDT
    DATE: April 7, 2020 TIME: 8:00am PT, 11:00am ET This webinar sets out to establish why quality control is key to robust, reliable, reproducible science. We will look at best practice criteri...
    JAN 23, 2020 9:00 AM PST
    C.E. CREDITS
    JAN 23, 2020 9:00 AM PST
    DATE: January 23, 2020 TIME: 9:00am PST, 12:00pm EST...
    FEB 26, 2020 9:00 AM PST
    C.E. CREDITS
    FEB 26, 2020 9:00 AM PST
    DATE: February 26, 2020 TIME: 9:00am PST 3D cell culture and analysis and the study of organoids and spheroids are becoming more prevalent as a research method in publications as traditional...
    JUN 09, 2020 10:00 AM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    C.E. CREDITS
    JUN 09, 2020 10:00 AM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    DATE: June 9, 2020 TIME: 10:00am PT, 1:00pm ET The presentation will first discuss sepsis as a disease and then explain the importance of performing diagnostic tests in the clinical labora...
    MAY 08, 2020 10:00 AM PDT
    C.E. CREDITS
    MAY 08, 2020 10:00 AM PDT
    DATE: May 8, 2020 TIME: 10:00am PT, 11:00am MT, 1:00pm ET The application of next generation sequencing to interrogate immune repertoires and methods in which these highly complex dataset...
    JUN 23, 2020 10:00 AM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    C.E. CREDITS
    JUN 23, 2020 10:00 AM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    DATE: June 23, 2020 TIME: 10:00am PT Human mesenchymal stromal or stem cells (MSCs)-based immunomodulation treatment has been proposed as a suitable therapeutic approach for many diseases, s...
    Loading Comments...
    Show Resources
    Attendees
    • See more